Mutations within these genes (PS1/PS2/APP) affect a common pathogenic pathway in APP synthesis and proteolysis, which lead to excessive production of amyloid β, and the accumulation and deposition of amyloid β formed senile plaque acts as a major pathologic lesion of AD. The gene discussed is PSEN2; the disease is Alzheimer disease.